PERIOD ENDING | 29-Jun-03 | 30-Mar-03 | 29-Dec-02 | 29-Sep-02 |
Total Revenue | 921,608 | 1,043,043 | 1,097,169 | 873,886 |
Cost of Revenue | 326,902 | 381,928 | 388,001 | 312,087 |
|
Gross Profit | 594,706 | 661,115 | 709,168 |
-
|
|
| Operating Expenses |
| Research Development | 135,690 | 131,801 | 112,479 | 109,969 |
| Selling General and Administrative | 117,486 | 135,724 | 147,999 | 131,847 |
| Non Recurring | 3,757 | 160,145 |
-
| 459 |
| Others | 1,951 | 1,965 | 1,972 | 66,759 |
| |
| Total Operating Expenses | 258,884 | 429,635 |
-
| 309,034 |
|
|
Operating Income or Loss | 335,822 | 231,480 | 446,718 | 252,765 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 44,190 | (49,278) | (50,588) | (15,314) |
| Earnings Before Interest And Taxes | 380,254 | 218,755 | 396,130 | 237,451 |
| Interest Expense | 9,763 | 3,879 | 6,881 | 8,374 |
| Income Before Tax | 370,491 | 214,876 | 389,249 | 229,077 |
| Income Tax Expense | 178,802 | 111,860 | 147,915 | 38,795 |
| Minority Interest | 242 | 36,553 |
-
|
-
|
| |
| Net Income From Continuing Ops | 191,689 | 103,016 | 241,334 | 190,282 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
Net Income | 191,689 | 103,016 | 241,334 | 190,282 |
Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
Net Income Applicable To Common Shares | $191,689 | $103,016 | $241,334 | $190,282 |
|